GSK has announced that it will be acquiring Boston Pharmaceuticals’ phase 3-ready liver disease candidate in a deal worth up to $2bn. Efimosfermin alfa is an investigational drug in clinical ...

Delphia Therapeutics has appointed David Kerstein as Chief Medical Officer (CMO). Delphia is a biopharmaceutical company pioneering an innovative new area of cancer biology – activation lethality – ...

For pharma brands, AI visibility is no longer just a digital question, it is fast becoming a brand strategy imperative ...

UK market access needs the right conditions nationally, along with subnational investment and delivery locally ...

Eli Lilly is to acquire LimmaTech Biologics and Vaccine Company. Along with its acquisition of Curevo, the companies will ...

The National Institute for Health and Care Excellence (NICE) has recommended Genmab UK’s Tivdak (tisotumab vedotin) for ...

In the fast-paced environment of clinical medicine, it is easy to focus solely on data and outcomes. However, as Dr. Toyin ...

The “problem” in healthcare comms is rarely what you say, it’s whether people can act on it. This article explains how we ...

This year, we welcome Simon Bates as the new Chair of the judging panel, someone who has been a judge and steering group ...

Eli Lilly has announced that it will acquire Curevo to expand the company’s research and development efforts into infectious ...

Over the last decade, the trial landscape has been undergoing reforms to become more focused on enrolling a diverse ...

Moderna has appointed Piyali Mukherjee as Head of Medical Affairs, Europe and Middle East. She will be based in Switzerland ...